S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NASDAQ:OCUL

Ocular Therapeutix SEC Filings & 10K Form

$6.16
-0.35 (-5.38%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.08
$6.60
50-Day Range
$6.16
$12.07
52-Week Range
$6.08
$24.30
Volume
560,500 shs
Average Volume
1.01 million shs
Market Capitalization
$471.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.85

Ocular Therapeutix (NASDAQ:OCUL) SEC Filings

DateFilerForm TypeView
07/22/2021
3:33 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2021
7:04 PM
Ocular Therapeutix (Issuer)
Williams Leslie J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
7:03 PM
Ocular Therapeutix (Issuer)
Warden Charles M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
7:02 PM
Ocular Therapeutix (Issuer)
PEACOCK BRUCE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
7:01 PM
LINDSTROM RICHARD L MD (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
7:01 PM
Hong Seung Suh (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
7:00 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
3:34 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2021
8:05 PM
LINDSTROM RICHARD L MD (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2021
3:08 PM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2021
3:18 PM
Ocular Therapeutix (Filer)
Form DEFA14A
04/29/2021
5:31 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2021
3:25 PM
Ocular Therapeutix (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/19/2021
3:31 PM
Goldstein Michael H. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
3:31 PM
Kitchen Patricia (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
3:30 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
3:30 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
3:29 PM
Ocular Therapeutix (Issuer)
Strassburger Philip C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:31 PM
Ocular Therapeutix (Issuer)
Warden Charles M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
7:04 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2020
5:30 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2020
3:04 PM
Ocular Therapeutix (Filer)
Form 424B5
12/14/2020
4:21 PM
Ocular Therapeutix (Filer)
Form 424B5
12/14/2020
3:09 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2020
3:06 PM
Ocular Therapeutix (Filer)
Form S-3ASR
12/08/2020
5:14 PM
Ocular Therapeutix (Issuer)
Warden Charles M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
8:30 PM
Ocular Therapeutix (Issuer)
PEACOCK BRUCE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
3:21 PM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
3:11 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2020
7:13 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2020
3:06 PM
Ocular Therapeutix (Issuer)
SUMMER ROAD LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
5:58 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/14/2020
3:17 PM
Ocular Therapeutix (Filer)
Form 424B5
10/13/2020
4:24 PM
Ocular Therapeutix (Filer)
Form 424B5
10/13/2020
4:04 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2020
7:10 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2020
3:17 PM
Ocular Therapeutix (Issuer)
Strassburger Philip C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2020
3:05 PM
Ocular Therapeutix (Issuer)
Strassburger Philip C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2020
6:36 AM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2020
6:23 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2020
6:34 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2020
8:17 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2020
7:15 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2020
3:15 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2020
3:04 PM
LINDSTROM RICHARD L MD (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
3:04 PM
Hong Seung Suh (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
3:03 PM
Ocular Therapeutix (Issuer)
Williams Leslie J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
7:27 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2020
3:15 PM
Ocular Therapeutix (Issuer)
SUMMER ROAD LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
3:15 PM
Ocular Therapeutix (Subject)
SUMMER ROAD LLC (Filed by)
Form SC 13D/A
05/20/2020
3:27 PM
Ocular Therapeutix (Filer)
Form 424B5
05/14/2020
3:36 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2020
6:31 AM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2020
6:05 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2020
3:27 PM
Ocular Therapeutix (Filer)
Form DEFA14A
04/29/2020
3:23 PM
Ocular Therapeutix (Filer)
Form DEF 14A
04/28/2020
6:07 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2020
7:05 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2020
4:11 PM
Ocular Therapeutix (Subject)
SUMMER ROAD LLC (Filed by)
Form SC 13D/A
03/24/2020
8:42 PM
Ocular Therapeutix (Issuer)
SUMMER ROAD LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2020
8:34 PM
Ocular Therapeutix (Issuer)
SUMMER ROAD LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
8:35 PM
Ocular Therapeutix (Issuer)
SUMMER ROAD LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
3:13 PM
Ocular Therapeutix (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2020
7:50 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
10:19 AM
Ocular Therapeutix (Subject)
Versant Side Fund III, L.P. (Filed by)
Form SC 13G/A
02/05/2020
11:16 AM
BlackRock Inc. (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G/A
02/03/2020
5:28 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2020
5:28 PM
Kitchen Patricia (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2020
5:27 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2020
5:27 PM
Goldstein Michael H. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
6:45 PM
Ocular Therapeutix (Issuer)
Opaleye Management Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
4:15 PM
Ocular Therapeutix (Issuer)
Opaleye Management Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2019
5:26 PM
Ocular Therapeutix (Issuer)
Opaleye Management Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/12/2019
6:41 AM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
6:20 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2019
11:09 AM
Ocular Therapeutix (Filer)
Form CT ORDER
09/24/2019
7:32 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
3:10 PM
Ocular Therapeutix (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/03/2019
3:28 PM
Kitchen Patricia (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:22 PM
Kitchen Patricia (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/21/2019
7:13 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
6:21 PM
Notman Donald (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
6:21 PM
Ocular Therapeutix (Issuer)
Williams Leslie J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
7:21 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2019
4:20 PM
Hong Seung Suh (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
4:20 PM
Ocular Therapeutix (Issuer)
Warden Charles M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
4:19 PM
Ocular Therapeutix (Issuer)
PEACOCK BRUCE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
4:19 PM
Heier Jeffrey S. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
4:18 PM
LINDSTROM RICHARD L MD (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
4:18 PM
Hong Seung Suh (Reporting)
Ocular Therapeutix (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/10/2019
3:55 PM
Ocular Therapeutix (Issuer)
Sawhney Amarpreet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:53 PM
Mattessich Antony C. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:09 PM
Ocular Therapeutix (Issuer)
Sawhney Amarpreet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:06 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
5:31 AM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
3:40 PM
Man Group plc (Filed by)
Ocular Therapeutix (Subject)
Form SC 13G
05/30/2019
3:10 PM
Goldstein Michael H. (Reporting)
Ocular Therapeutix (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
3:07 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
3:14 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
3:40 PM
Ocular Therapeutix (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.